实用器官移植电子杂志 ›› 2026, Vol. 14 ›› Issue (2): 127-131.DOI: 10.3969/j.issn.2095-5332.2026.02.007

• 论著 • 上一篇    下一篇

肝硬化失代偿期合并肝性脊髓病患者肝移植术后长期随访分析

朱梦月,王兴强,涂金鹏,孙晓叶   

  1. 天津市第一中心医院移植随访科,天津 300192
  • 出版日期:2026-03-20 发布日期:2026-03-20

Long-term follow-up analysis after liver transplantation in patients with decompensated liver cirrhosis complicated by hepatic myelopathy

Zhu Mengyue,Wang Xingqiang,Tu Jinpeng,Sun Xiaoye.    

  1. Transplant Follow-Up Clinic,Tianjin First Central Hospital,Tianjin300192,China.

  • Online:2026-03-20 Published:2026-03-20

摘要:

 目的 探讨肝移植治疗肝硬化失代偿期合并肝性脊髓病患者的长期疗效及神经功能转归情况。 方法 本研究为一项单中心回顾性病例分析。纳入2014 年1 月至2025 年3 月于天津市第一中心医院长期随访的肝硬化失代偿期合并肝性脊髓病行肝移植手术的患者共9 例。收集基线资料、手术情况及随访数据。采用改良Rankin 量表(modified rankin scale,MRS)和改良Barthel 指数(modified barthel index MBI)评估患者神经功能残疾程度与日常生活能力。采用Wilcoxon 符号秩检验比较手术前后评分的差异。 结果 9 例男性患者均获随访,年龄为(46 .8 ±7.8)岁。术后末次随访时,患者MRS 评分中位数显著低于术前〔3.0(2.0~4.0)比4.0(4.0~4.0),P=0.034〕。MBI 评分中位数高于术前〔92 .0(85.0~100.0)比86.0(58.0~87.0),P=0.075〕,虽未达统计学显著性,但呈现明确的改善趋势。个案分析提示病程较短的患者可能获益更大。 结论 肝移植可显著改善肝性脊髓病患者的神经功能障碍,并显示出提升其日常生活能力的趋势,是治疗肝性脊髓病的有效手段。早期进行肝移植干预可能获得更佳的神经学预后。

关键词:

text-indent:0pt, vertical-align:middle, "> 肝移植, 肝性脊髓病, 功能恢复

Abstract:

Objective To evaluate the long-term efficacy and neurological outcomes of liver transplantation in patients with decompensated liver cirrhosis complicated by hepatic myelopathy. Methods This single-center retrospective case analysis included 9 patients with decompensated liver cirrhosis and hepatic myelopathy who underwent liver transplantation at Tianjin First Central Hospital between January 2014 and March 2025 and were followed up long-term. Baseline characteristics,surgical data,and follow-up information were collected. Neurological disability and activities of daily living were assessed using the modified rankin scale(MRS)and the Modified Barthel Index(MBI),respectively. The Wilcoxon signed-rank test was employed to compare score differences before and after surgery. Results All 9 male patients were followed up,with a mean age of(46 .8 ±7.8)years. At the final postoperative follow-up,the median MRS score was significantly lower than the preoperative score〔3 .0(2 .0,4.0)vs.4.0(4 .0~4.0),P=0.034〕. The median MBI score was hig her than the preoperative level〔92 .0(85 .0~100.0) vs. 86.0(58 .0~87.0),P=0.075〕;although this difference did not reach statistical significance,it indicated a clear trend towards improvement. Case analysis suggests that patients with a shorter disease course may benefitmore. Conclusion Liver transplantation can significantly improve neurological disability in patients with hepatic myelopathy and shows a trend towards enhancing their activities of daily living,proving to be an effective treatment for myelopathy and shows a trend towards enhancing their activities of daily living,proving to be an effective treatment for this condition. Early intervention with liver transplantation may lead to optimal neurological outcomes.

Key words:

text-indent:0pt, vertical-align:middle, "> Liver transplantation, Hepatic myelopathy, Recovery of function